CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-07-09). The draft was written by AI, all 4 cited sources were opened and checked for existence, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 144 · Search date 2026-07-09 · Methodology v0.6

Aronia,
does it really help with Antioxidant, blood pressure, and vascular effects?

30-Second Summary
C
Evidence Grade C · 43 · Safety caution
Antioxidant numbers and clinical vascular benefit need to be distinguished
What the
research shows
Aronia has small human studies examining cardiovascular surrogate markers such as oxidative-stress markers, blood pressure, and lipids. However, large RCTs proving cardiovascular events, progression of atherosclerosis, or long-term vascular benefits in generally healthy people are difficult to find.
What the
ads claim
Products combine phrases such as 'anthocyanins,' 'No. 1 antioxidant,' 'vascular cleansing,' and 'blood-pressure management.' The actual human evidence is concentrated on blood markers and blood-pressure changes in patients or high-risk groups.
*

Useful facts when choosing a product

  • Juice, powder, and flavonoid extracts differ greatly in polyphenol content.
  • It is difficult to directly transfer studies in people taking blood-pressure or lipid medications to preventive effects in generally healthy people.
  • Gastrointestinal discomfort may occur because of astringent components and acidity.
  • People taking blood-pressure medications or anticoagulants are safer checking supplement co-use with a clinician.
Gap Measurement · Verdict 144 · C 43
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Naruszewicz 2007 gave aronia flavonoid extract for 6 weeks to 44 statin users after myocardial infarction and reported improvements in blood pressure, oxidized LDL, hsCRP, and endothelin-1. Skoczynska 2007 reported effects of chokeberry juice on blood pressure, lipids, and oxidative markers in men with mild hypercholesterolemia. Broncel 2010 reported improvements in blood pressure, endothelin-1, and lipids in 25 patients with metabolic syndrome, but the sample was small and the control-group structure was limited. Overall, antioxidant and vascular claims are centered on intermediate surrogate markers.

02

Why this is classified as C (43)

Repeated human surrogate-marker studies place this above the lower end of C, but without large independent RCTs and clinical outcomes I do not raise it to B. It is C, 43 points.

Counterpoint. Changes in numbers such as blood pressure and oxidized LDL are biologically plausible. However, this judgment does not extend them to the broader claim that vascular health clinically improved.

Rejudgment record. Draft — Human surrogate-marker studies exist, but they are small, centered on patient populations, and lack clinical outcomes

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Naruszewicz M et al. 2007Randomized placebo-controlled trial44Unknown/extract studyBlood pressure, oxidized LDL, hsCRP, and endothelin-1Reported improvements in blood pressure and oxidative, inflammatory, and endothelial surrogate markers after 6 weeks of intake.Core
Skoczynska A et al. 2007Human intervention studyUnknownBlood pressure, lipids, and oxidative stressReported changes in some cardiovascular surrogate markers after intake of chokeberry juice.Supporting
Broncel M et al. 2010Small clinical trial25UnknownBlood pressure, lipids, and endothelin-1Reported improvements in blood pressure and some vascular surrogate markers after 2 months of intake.Supporting
§

Receipt — 4 References

Every cited source was opened and checked against the live page on 2026-07-09.

Naruszewicz M, Laniewska I, Millo B, Dluzniewski M. Combination therapy of statin with flavonoids rich extract from chokeberry fruits enhanced reduction in cardiovascular risk markers in patients after myocardial infarction. Atherosclerosis. 2007;194:e179-e184. DOI: 10.1016/j.atherosclerosis.2006.12.032.
checked
Skoczynska A, Jedrychowska I, Poreba R, et al. Influence of chokeberry juice on arterial blood pressure and lipid parameters in men with mild hypercholesterolemia. Pharmacol Rep. 2007;59 Suppl 1:177-182.
checked
Broncel M, Koziróg M, Duchnowicz P, et al. Aronia melanocarpa extract reduces blood pressure, serum endothelin, lipid, and oxidative stress marker levels in patients with metabolic syndrome. Med Sci Monit. 2010;16:CR28-CR34.
checked
Sidor A, Gramza-Michalowska A. Black chokeberry Aronia melanocarpa L. A qualitative composition, phenolic profile and antioxidant potential. Molecules. 2019;24:3710. DOI: 10.3390/molecules24203710.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-09 · Corrections: none

Cite this verdict

Aronia (chokeberry) x antioxidant, blood pressure, and vascular effects Evidence Grade C card
[Chamgap] Aronia (chokeberry) x antioxidant, blood pressure, and vascular effects — Evidence Grade C·43. 4 cited sources checked. Source: https://health-receipt.pages.dev/en/verdicts/heart/aronia-antioxidant-blood-pressure-vascular/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.